A case of microangiopathic hemolytic anemia associated with breast cancer: Improvement with chemoendocrine therapy

Breast Cancer

Volumn 4, Issue 1, 1997, Pages 39-42

  Narita, Masashi ^a   Nakao, Kazuyasu ^a   Ogino, Nobuo ^a   Emoto, Takashi ^a   Nakahara, Masaaki ^a   Yumiba, Takeyoshi ^a   Tsujimoto, Masahiko ^a  

^a OSAKA POLICE HOSPITAL   (Japan)

Author keywords

Breast cancer; Disseminated intravascular coagulation (DIC); Medroxyprogesterone acetate (MPA); Microangiopathic hemolytic anemia (MAHA)

Indexed keywords

EID: 1642359629     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967054     Document Type: Article

References (15)

1. Brain MC, Dacie JV, Hourihane DO'B: Microangiopathic haemolytic anaemia; The possible role of vascular lesions in pathogenesis. Br J Haematol 8:358-374, 1962.
2. Sathawarawong W: Thrombotic thrombocytopenic purpura (TTP); 4 cases reports and review of the literature. J Med Assoc Thai 78:322-331, 1995.
3. Antman KH, Skarin AT, Mayer RJ, et al: Microangiopathic hemolytic anemia and cancer; A review. Medicine 58:377-384, 1979. (Pubitemid 10234880)
4. Japan Mammary Cancer Society: General Rules for Clinical and Pathological Record of Mammary Cancer, 11th ed, Kanehara, Tokyo, 1992.
5. Lohrmann HP, Adam W, Heymer, et al: Microangiopathic hemolytic anemia in metastatic carcinoma. Ann Intern Med 79:368-375, 1973.
6. Brain MC, Azzopardi JG, Baker LRI, et al: Microangiopathic hemolytic anemia and mucin-forming adenocarcinoma. Br J Haematol 18:183-193, 1970.
7. Bull BS, Rubenberg ML, Dacie JV, et al: Microangiopathic haemolytic anemia; Mechanisms of red cell fragmentation in vitro studies. Br J Haematol 14:643-652, 1968.
8. Hilgard P, Gordon-Smith EC: Microangiopathic haemolytic anaemia and experimental tumour-cell emboli. Br J Haematol 26:651-659, 1974.
9. Rauch AE, Tartaglia AP, Kaufman B, et al: RBC fragmentation and thymoma. Arch Intern Med 144:1280-1282, 1984. (Pubitemid 14121081)
10. Lin Y-C, Chang H-K, Sun C-F, et al: Microangiopathic haemolytic anemia as an initial presentation of metastatic cancer of unknown primary origin. South Med J 88:683-687, 1995.
11. Rodenburg CJ, Noony MA, Briët E: Microangiopathic haemolytic anemia with advanced breast carcinoma; Improvement with chemotherapy. Neth J Med 28:169-171, 1985. (Pubitemid 15112273)
12. Nordstrom B, Strang P: Microangiopathic haemolytic anemia (MAHA) in cancer; A case report and review. Anticancer Res 13:1845-1850, 1993. (Pubitemid 2008264)
13. Collins PW, Jones L, Pocock C, et al: Microangiopathic haemolysis associated with occult carcinoma. Clin Lab Haematol 13:245-249, 1991.
14. Yamamoto H, Noguchi S, Miyauchi K: Changes in hematologic parameters during treatment with medroxyprogesterone acetate for breast cancer. Jpn J Cancer Res 82:420-425, 1991.
15. Japan Advanced Breast Cancer Group and Japan Clinical Oncology Group: Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Jpn J Cancer Res 84:455-461, 1993.